Unilab Reports Profit of $3.2 Million in Quarter
Unilab Corp., a Tarzana-based provider of medical testing services, posted first-quarter net income of $3.2 million on a 3% gain in sales.
Unilab said it didn’t have any net income during the same period a year ago after the payment of preferred dividends and before an accounting change.
Revenue in the latest quarter rose to $57 million from $55 million.
As previously reported, Unilab has agreed to a restructuring plan that includes selling its non-California labs to one of its major stockholders, Corning Inc., a Corning, N.Y.-based maker of glass and communications products and a provider of lab services.
In exchange, Corning will assume $70 million of Unilab’s $93 million of current debt and reduce its ownership interest in Unilab to about 12% from the current 43%. Corning will also transfer its British clinical laboratory company, J.S. Pathology PLC, to Unilab.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
